Roles of light transmission aggregometry and CYP2C19 genotype in predicting ischaemic complications during interventional therapy for intracranial aneurysms.
Yangyang ZhouWenqiang LiChao WangRuhang XieYongnan ZhuQichen PengLimin ZhangHong-Qi ZhangYu-Xiang GuShiqing MuJian LiuXinjian YangPublished in: Stroke and vascular neurology (2023)
ADP-MPA can predict ischaemic complications during endovascular treatment of intracranial aneurysms. Patients with flow diverters require stronger antiplatelet medication than patients with traditional stents.